Ground-breaking clinical data from insight trial presented at viva

Study outcomes demonstrate safety and efficacy of pantheris for treatment of in-stent restenosis redwood city, ca / accesswire / october 7, 2021 / avinger, inc. (nasdaq:avgr), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system for diagnosis and treatment of peripheral artery disease (pad), today announced that clinical data from the insight study were presented during the late-breaking clinical trials session at the viva (vascular interventional advances) conference in las vegas. the insight trial was designed to evaluate the safety and effectiveness of avinger's pantheris image-guided atherectomy system for treating in-stent restenosis (isr) in lower extremity arteries.
AVGR Ratings Summary
AVGR Quant Ranking